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 Abstract
Objectives: The aim of this retrospective study was to review placenta previa cases and determine the prognostic 
factors effective on morbidity and mortality and to evaluate the strategy of anesthetic management. 
Material and methods: 65 women with placenta previa scheduled for elective or emergency cesarean sections 
from 2004 to 2009 were examined. Patient demographic data, surgery and obstetric characteristics, anesthetic 
techniques, blood transfusions, the values of hemoglobin and complications were recorded. 
Results: Mostly, general anesthesia was preferred in the parturients with placenta previa (86.2%, 56/65). 9 patients 
(13.8%), 2 of whom were converted to general anesthesia due to bleeding and prolonged surgery, received regional 
anesthesia. 37 of 65 women (56.9%) with placenta previa had had cesarean sections previously. More than half 
of these patients (21/37, 56.7%) had abnormally invasive placentation and 16 of 21 cases underwent cesarean 
hysterectomy. The incidence of complications in women with previous cesarean section with abnormally invasive 
placentation was higher than in the other women (p<0.0001). Three patients were transferred to the intensive care 
unit; 2 were intubated and mechanical ventilation was applied, and 1 died of hemorrhage.  
Conclusions: Anesthetic management is important for parturients with placenta previa who had previous cesarean 
section or abnormally invasive placentation. We found that general anesthesia was our method of preference for 
placenta previa as we wished to avoid the risk of bleeding. However, regional anesthesia can be safe in patients 
lacking any abnormally invasive placentation.  
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Introduction  
Primary	 cesarean	 section	 (C/S)	 often	 leads	 to	 repeat	 C/S,	
which	 may	 lead	 to	 placenta	 previa	 and	 abnormally	 invasive	
placentation	 [1].	 Placenta	 previa,	 with	 an	 incidence	 of	 0.3-
0.6%,	 occurs	 when	 part	 of	 the	 placenta	 implants	 within	 the	
lower	uterine	segment.	It	is	one	of	the	major	causes	of	massive	
obstetric	hemorrhage	and	can	result	in	increased	maternal,	fetal	
and	neonatal	morbidity	or	mortality	[1,	2].	Placenta	previa	is	also	
a	risk	factor	for	abnormally	invasive	placentation	and	can	cause	
increased	hysterectomy	rate	[2,	3].	
Abnormally	 invasive	 placentation,	 comprised	 of	 placenta	
accreta,	 increta,	 and	percreta,	 is	 a	 leading	cause	of	postpartum	
hemorrhage	 and	 is	 also	 associated	 with	 significant	 maternal	
morbidity.	 Surgical	 morbidity	 may	 be	 related	 to	 the	 degree	
of	 placental	 invasion	 [3].	 In	 the	 literature,	 the	 term	 “placenta	
accreta”	 or	 “abnormal	 placentation”	 are	 used	 to	 define	 any	
degree	of	placental	invasion,	but	we	prefer	the	term	“abnormally	
invasive	 placentation”	 [3-5].	 The	 incidence	 of	 abnormally	
invasive	 placentation	 ranges	 from	 1	 in	 540	 to	 1	 in	 93.000	
deliveries	 [6].	 This	 incidence	 appears	 to	 be	 increasing,	 most	
likely	as	a	consequence	of	the	rising	cesarean	delivery	rate	over	
the	past	several	decades	[3].	There	is	a	need	for	reliable	antenatal	
diagnosis	for	these	serious	conditions	because	it	is	necessary	to	
be	prepared	for	managing	a	major	hemorrhage	[1,	7,	8].	If	these	
pregnancies	can	be	identified	before	delivery,	the	place	and	time	
of	delivery,	as	well	as	the	surgical	approach	can	be	planned	ahead	
and	decrease	the	blood	loss	[9].		
The	 aim	 of	 this	 retrospective	 study	 was	 to	 evaluate	 the	
incidence	of	placenta	previa	and	abnormally	invasive	placentation,	
anesthetic	management	 and	 preparations	 before	 surgery,	 blood	
transfusion	 requirements,	 and	 the	 rate	 of	 complications,	 and	
to	 determine	 the	 prognostic	 factors	 effective	 on	 the	 involved	
morbidity	 and	 mortality	 and	 define	 the	 strategy	 of	 anesthetic	
management	in	our	institution.		
Materials and Methods 
After	 ethics	 committee	 approval,	 a	 retrospective	 study	 for	
years	 2004	 to	 2009	was	 carried	 out	 in	 our	 university	 hospital	
with	the	help	of	a	computerized	obstetric	database	and	hospital	
records.	All	cases	with	placenta	previa	were	reviewed.	For	each	
patient,	the	following	information	was	recorded:	age,	gravidity,	
parity,	gestational	age,	duration	of	surgery,	number	of	previous	C/
Ss,	the	nature	of	the	surgery	(emergency	or	elective),	abnormally	
invasive	 placentation,	 anesthetic	 technique,	 placed	 intravenous	
lines,	 amount	 of	 blood	 products	 transfused,	 preoperative	 and	
postoperative	 blood	 hemoglobin	 concentrations,	 maternal	
mortality	and	morbidity,	and	length	of	hospital	stay.		
Placenta	 previa	 was	 defined	 by	 ultrasound	 as	 a	 partial	
or	 complete	 covering	 of	 the	 internal	 cervical	 os	 by	 the	
placenta.	Abnormally	 invasive	 placentation	 was	 diagnozed	 by	
histopathological	or	clinical	criteria,	the	latter	including	clinical	
symptoms	and	findings	of	imaging	techniques.	
Statistical	 analysis	 was	 performed	 with	 the	 SPSS	 (SPSS	
for	Windows,	 release	 16.0)	 statistical	 package.	The	 results	 are	
presented	 as	 means±standard	 deviation,	 medians	 (range)	 or	
numbers	(%),	as	appropriate.	Due	to	the	lack	of	agreement	with	
normal	distribution,	demographic	data	and	obstetric	characteristics	
were	presented	as	medians	(range)	and	percentages.	Intraoperative	
complications	 were	 compared	 between	 the	 groups	 using	 Chi-
Square	 test.	 Hemoglobin	 values	 and	 blood	 transfusions	 were	
analyzed	using	Kruskal	Wallis	and	Mann-Whitney	 tests.	Blood	
and	 blood	 product	 transfusion	 between	 patients	 who	 received	
general	and	regional	anesthesia	were	analyzed	using	Chi-Square	
test	 confirmed	 by	 Fisher’s	 Exact	 test.	 P	 value	 of	 <0.05	 was	
considered	statistically	significant.		
Results 
In	 the	 6-year	 analysis,	 65	 women	 with	 placenta	 previa	
scheduled	 for	 elective	 or	 emergency	 C/S	 were	 examined.	
The	 incidence	 of	 placenta	 previa	was	 found	 to	 be	 0.5%	 of	 all	
 Streszczenie
Cel pracy: Celem tego retrospektywnego badania była analiza przypadków łożyska przodującego pod kątem 
oceny czynników prognostycznych wpływających na zachorowalność i śmiertelność oraz ocena postępowania 
anestezjologicznego.
Materiał: Przeanalizowano 65 przypadków kobiet z łożyskiem przodującym zakwalifikowanych do elektywnego 
lub pilnego cięcia cesarskiego w latach 2004-2009.Zebrano następujące dane: demograficzne, wywiad operacyjny 
i położniczy, techniki anestezjologiczne, transfuzje krwi, poziomy hemoglobiny i powikłania.
Wyniki: Preferowaną metodą znieczulenia u rodzących z łożyskiem przodującym było znieczulenie ogólne (86,2%; 
56/65). Przewodowe znieczulenie otrzymało 9 pacjentek (13,8%) ale u 2 z nich trzeba było przejść na znieczulenie 
ogólne z uwagi na krwawienie i przedłużony czas operacji. 37 z 65 kobiet (56,9%) z łożyskiem przodującym miało 
cięcie cesarskie w poprzedniej ciąży. Więcej niż połowa tych pacjentek (21/37, 56,7%) miała nieprawidłowo 
utworzone łożysko a 16 z 21 przeszło histerektomię położniczą. Częstość powikłań u kobiet po cięciu cesarskim w 
wywiadzie i z nieprawidłowo utworzonym łożyskiem w analizowanym materiale była wyższa niż u innych pacjentek 
(p<0,0001). Trzy pacjentki przekazano do oddziału intensywnej opieki medycznej, 2 zaintubowano i wentylowano 
mechanicznie, 1 zmarła z powodu krwotoku. 
Wnioski: Postępowanie anestezjologiczne jest istotne u rodzących z łożyskiem przodującym po przebytym cięciu 
cesarskim lub nieprawidłowo utworzonym łożyskiem. Preferowaną metoda anestezjologiczną było znieczulenie 
ogólne w przypadkach łożyska przodującego w celu uniknięcia ryzyka krwawienia. Znieczulenie przewodowe może 
być bezpieczną metodą u pacjentek bez nieprawidłowości łożyska.
 Słowa kluczowe: łożysko przodujące / łożysko wrośnięte / cięcie cesarskie / znieczulenie /   
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parturitions.	 One	 case	 (1.5%;	 1/65)	 was	 fatal.	 Placenta	 previa	
marginalis	was	detected	in	3	(4.6%)	patients.	Demographic	data	
of	these	patients,	operation	time	and	length	of	hospital	stay	are	
shown	in	Table	I.		
Forty	 two	 (64.6%)	 patients	 were	 elective	 cases,	 and	 37	
(56.9%)	women	with	placenta	previa	had	experienced	previous	
C/S.	More	than	half	of	these	patients	(21/37,	56.7%)	had	abnor-
mally	 invasive	 placentation.	 Intrauterine	 fetal	 death occurred	
in	case	of	3	babies (Table	II).	Only	1	patient	with	primary	C/S	
underwent	subtotal	hysterectomy.	She	had	a	history	of	4	dilata-
tion	and	curettage	procedures	and	was	diagnozed	postoperatively	
with	placenta	increta.	
The	incidence	of	intraoperative	complications	in	the	women	
with	 previous	 C/S	 with	 abnormally	 invasive	 placentation	 was	
higher	 than	 in	 the	 other	 women	 (p<0.0001).	 In	 this	 group,	
3	 patients	 who	 had	 placenta	 percreta	 were	 transferred	 to	 the	
intensive	 care	 unit;	 2	were	 intubated	 and	 received	mechanical	
ventilation,	and	1	died	from	uncontrolled	hemorrhage.		
General	 anesthesia	 was	 performed	 in	 56	 of	 65	 (86.1%)	
patients,	whereas	9	(13.9%)	patients	had	regional	anesthesia	(in	
2	 cases	 spinal	 anesthesia	 was	 converted	 to	 general	 anesthesia	
owing	to	excessive	bleeding	and	prolonged	surgery).	One	of	the	
two	who	received	spinal	anesthesia	was	diagnozed	with	placenta	
percreta	histopathologically,	 and	 total	 abdominal	hysterectomy,	
bladder	repair	and	uterine	artery	ligation	were	performed.	Subtotal	
hysterectomy	was	performed	in	the	second	patient	who	received	
spinal	anesthesia	due	to	placenta	increta.	These	two	patients	had	
had	previous	C/S.		
There	 was	 no	 statistically	 significant	 difference	 in	 the	
values	of	baseline	hemoglobin	concentration	between	the	groups	
(p=0.13),	but	other	hemoglobin	variables,	except	for	the	highest	
value	in	the	postoperative	period,	were	significantly	lower	in	the	
group	 of	 previous	 C/S	 with	 abnormally	 invasive	 placentation.	
The	 amounts	 of	 transfused	 red	 blood	 cells	 and	 fresh	 frozen	
plasma	were	higher	in	this	group	(p<0.05)	(Table	III).	Extensive	
blood	 and	 blood	 product	 transfusions	 were	 performed	 only	 in	
2	 patients.	 In	 one	 of	 them,	 spinal	 anesthesia	was	 converted	 to	
general	anesthesia	and	the	patient	was	diagnozed	with	placenta	
percreta.	 This	 patient	 died	 from	 bleeding	 in	 the	 postoperative	
period.	The	second	patient	received	general	anesthesia	and	was	
also	diagnozed	with	placenta	percreta.	However,	these	2	cases	of	
utmost	severity	did	not	create	significant	differences	between	the	
groups	in	total	blood	and	blood	product	transfusions	according	to	
the	anesthetic	technique	used	(Table	IV).		
As	a	result	of	our	study,	we	established	that	in	most	of	the	
cases	(62%,	40/65)	two	or	more	large-bore	intravenous	lines	were	
placed	prior	to	the	beginning	of	surgery.	In	addition,	arterial	lines	
were	inserted	in	19	(29.2%)	patients,	and	central	venous	catheters	
after	anesthesia	induction	in	another	10	(15.4%).		
Discussion 
This	 retrospective	 study	 found	 the	 incidence	 of	 placenta	
previa	 to	 be	 0.5%,	 in	 accordance	 with	 other	 reports	 [10,	 11].	
General	 anesthesia	was	 our	method	 of	 preference	 for	 placenta	
previa	as	we	feared	increased	intraoperative	blood	loss.	Most	of	
Clinical data Number of patients (%) 
Medical history: 
        Unremarkable 
        Positive for hypertension or endocrine and renal disease  
        Positive for emergency/elective C/S (n,%)
50 (76.9%) 
15 (23.1%) 
23 (35.4%) / 42 (64.6%) 
With no previous C/S (n,%) 28 (43.1 %) 
With previous C/S (n,%) 37 (56.9 %) 
Abnormally invasive placentation  
        Placenta accreta  
        Placenta increta  
        Placenta percreta  
28 (43.1%) 
12 (18.5%) 
8 (12.3%) 
8 (12.3%) 
Abnormally invasive placentation and previous C/S  21/37 (56.7%) 
Abnormally invasive placentation and no previous C/S  7/28 (25%) 
Maternal mortality rate 1/65 (1.5%) 
Intrauterine fetal death rate 3/65 (4.6%) 
Table II. Details of medical, surgical, and obstetrical patient characteristics (N = 65). C/S: cesarean section.  
Clinical data Median (range) 
Age (years) 31 (22-42)
Patient weight (kg) 74 (40-111)
Patient height (cm) 162 (138-174)
Gravidity 3 (1-6)
Parity 1 (0-3)
Gestational age (weeks) 34 (18-39)
Duration of surgery (min) 75 (60-195)
Postoperative stay (days) 3 (1-17)
Table I. Principal clinical characteristics of the studied population (N = 65).  
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the	patients	had	undergone	a	previous	C/S,	and	these	patients	had	
abnormally	 invasive	placentation.	We	 found	 that	 intraoperative	
complications	 in	 women	 with	 previous	 C/S	 with	 abnormally	
invasive	placentation	were	higher	than	in	other	patients.	
When	placenta	previa	 is	accompanied	by	a	history	of	C/S,	
the	risk	of	abnormally	invasive	placentation	increases	[3,	10,	12].	
Miller	 et	 al.	 showed	 that	 placenta	 accreta	 occurred	 in	 9.3%	of	
women	with	placenta	previa	and	in	1	of	22154	without	placenta	
previa	 [13].	 Placenta	 previa-accreta	 is	 associated	 with	 higher	
maternal	morbidity	but,	fortunately,	neonatal	outcome	is	similar	
when	compared	to	patients	with	placenta	previa	alone	[14].	The	
choice	of	the	best	technique	of	anesthesia	for	C/S	in	women	with	
placenta	previa	remains	a	controversial	issue	[15].	There	has	been	
extensive	administration	of	general	anesthesia	for	C/S	whenever	
placenta	previa	is	the	indication,	as	women	with	placenta	previa	
may	constitute	a	clinical	dilemma	for	an	anesthetist	[16].	However,	
regional	 anesthesia	 in	women	with	placenta	previa	 is	 also	 safe	
[17].	Parekh	et	al.	reported	that	regional	anesthetic	technique	was	
used	in	210	out	of	350	(60%)	patients	and	they	preferred	spinal	
anesthesia	[1].	Moreover,	Imarengiaye	et	al.	suggested	that	spinal	
anesthesia,	which	was	used	in	29	out	of	81	women	(35.8%),	may	
be	useful	 in	patients	with	placenta	previa	 [16].	McShane	et	 al.	
reported	that	the	incidence	of	regional	anesthesia	with	no	maternal	
morbidity	or	mortality	in	women	with	placenta	previa	was	25%	
[2].	Generally,	it	is	believed	that	the	sympathetic	blockade	induced	
by	 regional	 anesthesia	 can	 make	 it	 difficult	 or	 impossible	 to	
control	arterial	pressure,	resulting	in	severe	hemorrhage,	and	that	
general	anesthesia	is	preferable	in	the	light	of	possible	increased	
Clinical feature
Previous C/S,   
with abnormally 
invasive placenta
(N = 21)
Previous C/S, 
without abnormally 
invasive placenta
(N = 16)
No previous C/S,   
with abnormally 
invasive placenta
(N = 7)
No previous C/S, 
without abnormally 
invasive placenta
(N = 21)
Intraoperative complications (n, %) 17 (81%) 0* 1 (14.3%)* 0*
Total hysterectomy  
Subtotal hysterectomy 
Bladder repair 
Uterine artery ligation
13
3
7
6
0
0
0
0
1
0
0
0
0
0
0
0
No complication at all (n, %) 4 (19%) 16 (100%) 6 (85.7%) 21 (100%)
General anesthesia (n, %) 18 (85.7%) 14 (87.5%) 6 (85.7%) 18 (85.7%)
Spinal anesthesia (n, %) 3 (14.3%) 1 (6.25%) 1 (14.3%) 2 (9.5%)
Epidural anesthesia (n, %) 0 1 (6.25%) 0 1 (4.8%)
Hemoglobin concentration (median) 
Preoperative values (g/dL) 
Lowest intraoperative value (g/dL) 
Highest intraoperative value (g/dL) 
Lowest postoperative value (g/dL) 
Highest postoperative value (g/dL) 
11 (8-13)
8 (5-11)
9 (6-11.4)
9 (5-12)
10.2 (7-12)
11.3 (9-14)
9.9 (8-12)*
10.2 (8.1-12)*
9.8 (7.5-12.8)*
11 (8.5-13)
12 (10-14)
10 (7-12)*
11 (8.5-12.5)*
10 (9.6-12)*
12 (10-12.4)*
11.1 (9-13)
9.9 (8-11)*
10 (8.8-12)*
10 (8.9-12)*
11 (9.4-12)
Blood product transfusion (median) 
Red blood cells (units)  
Fresh frozen plasma (units)  
5 (0-30)
1 (0-18)
0 (0-4)*
0 (0-2)*
0 (0-4)*
0*
0 (0-4)*
0*
Table III. Surgical and anesthetic patient characteristics (N = 65) with division into subgroups according to history of cesarean section (C/S) and presence of abnormally 
invasive placentation. Data are presented as: number of patients (n) and percentage (%), or median (range).  
*p <0.05 for women with previous C/S with abnormally invasive placentation versus other groups.   
Blood product
General anesthesia
(N = 56)
Regional anesthesia
(N = 9)
Number of 
patients
Number of units 
used 
Number of 
patients
Number of units 
used 
Red blood cells  29 4 (1-20) 6 2 (1-30)
Donor blood  10 1.5 (1-5) 1 10
Fresh frozen plasma  12 3 (1-13) 1 18
Platelets  1 1 1 5
Table IV. Amount of blood products transfused in the two anesthetic groups, according to the technique used. Data are presented as medians (range).  
Fisher’s Exact test was used for statistical analysis. No significant differences between the groups were noted.   
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blood	loss	[1,	18].	Yet,	Hong	et	al.	compared	general	and	epidural	
anesthesia	 in	 terms	 of	maternal	 hemodynamics	 and	 blood	 loss	
for	C/S	with	 placenta	 previa	 [8].	 Intraoperative	 blood	 loss	 did	
not	 differ	 significantly	 between	 the	 groups,	 whereas	 general	
anesthesia	resulted	in	lower	immediate	postoperative	hematocrit	
level,	and	 the	patients	 in	 the	general	anesthesia	group	received	
significantly	 more	 transfusions	 than	 in	 the	 epidural	 anesthesia	
group.	The	authors	concluded	that	epidural	anesthesia	is	superior	
to	 general	 anesthesia	 in	 elective	 C/S	 for	 placenta	 previa	 with	
regard	to	maternal	hemodynamics	and	blood	loss.	Parekh	et	al.	
reported	 that	205	of	350	patients	with	placenta	previa	received	
regional	 anesthesia	with	 no	 problem	 in	 blood	 pressure	 control	
[1].	In	their	study,	there	was	a	significant	difference	in	estimated	
blood	loss	between	regional	and	general	anesthesia	groups	(613	
±	367	mL	versus	756	±	518	mL,	respectively).	
Noteworthy,	 placenta	 previa	 combined	 with	 abnormally	
invasive	placentation	is	associated	with	severe	hemorrhage	[19].	
However,	 in	 most	 of	 the	 studies	 cited	 above,	 parturients	 with	
placenta	previa	alone.	In	our	hospital,	total	intraoperative	blood	
loss	was	not	recorded	in	the	follow-up	documentation.	Thus,	we	
were	only	 able	 to	 evaluate	hemoglobin	values,	 the	 amounts	of	
transfused	 red	 blood	 cells	 and	 fresh	 frozen	 plasma.	Although	
there	were	no	significant	differences	with	regard	to	hemoglobin,	
total	blood	and	blood	product	transfusions	between	regional	and	
general	anesthesia	groups;	differences	were	found	for	the	group	
of	women	with	history	of	previous	C/S	and	abnormally	invasive	
placentation.	These	data	lead	us	to	the	conclusion	that	obstetric	
characteristics	are	more	important	than	anesthetic	techniques	in	
intraoperative	blood	loss	for	placenta	previa.		
In	patients	with	peripartum	hemorrhage,	the	primary	goal	is	
early	treatment	of	the	cause	of	bleeding.	Placement	of	wide-bore	
venous	access	and,	if	necessary,	central	venous	catheters,	are	the	
essential	prerequisits	 for	 effective	 treatment	 [20].	 In	our	 study,	
we	established	that	two	or	more	large-bore	intravenous	lines	had	
been	placed	prior	to	the	beginning	of	surgery	in	the	majority	of	
cases	(62%),	while	arterial	lines	inserted	in	19	(29.2%)	patients,	
and	central	venous	catheters	in	10	(15.4%)	patients.	This	was	a	
reassuring	finding.		
Generally,	 maternal	 morbidity	 and	 mortality	 significantly	
increase	 with	 abnormally	 invasive	 placentation,	 rather,	 than	
anesthetic	technique	used	in	the	parturients	with	placenta	previa	
[2,	 21].	Risk	 factors	 for	 hysterectomy	 in	 these	women	 include	
placenta	 accreta	 and	 previous	C/S	 [8].	As	mentioned,	 in	 some	
careful	studies	 [1,	2],	no	maternal	morbidity	attributable	 to	 the	
anesthetic	 techniques	 used	was	 established.	We	 found	 that	 the	
risk	 of	 abnormally	 invasive	 placentation	 increases	 even	 more	
with	previous	C/S	with	the	presence	of	placenta	previa.	In	line,	
the	incidence	of	maternal	morbidity	was	higher	in	patients	with	
previous	C/S	and	abnormally	invasive	placentation.		
The	 results	 of	 this	 retrospective	 analysis	 show	 that	 in	 our	
hospital	 general	 anesthesia	 was	 often	 preferred	 for	 placenta	
previa	 in	 order	 to	 decrease	 the	 risk	 of	 bleeding.	 However,	
this	 view	 may	 be	 challenged	 and	 regional	 anesthesia	 may	 be	
preferred,	except	for	women	with	previous	gynecologic	surgery	
or	C/S,	since	then	intraoperative	complications	and	abnormally	
invasive	placentation	occur	more	often.	In	order	to	reduce	anxiety,	
however,	a	possibility	of	prolonged	surgery	should	be	explained	
to	parturients	who	are	going	to	receive	regional	anesthesia.	For	
women	 that	 are	 in	 high	 risk	 groups,	 two	 or	 more	 large-bore	
intravenous	lines	should	be	placed	and	both	fresh	frozen	plasma	
and	red	blood	cells	should	be	prepared	before	surgery.	
The	management	of	obstetric	hemorrhage	requires	a	multi-
disciplinary	approach.	The	obstetrician	and	the	anesthesiologist	
should	both	be	aware	of	 the	possibility	of	massive	hemorrhage	
and	intra-	or	postpartum	complications	requiring	hysterectomy	in	
these	high	risk	patients.	Thus,	in	the	antenatal	period,	the	obstetri-
cian	should	evaluate	the	patients	in	terms	of	placental	adhesion	
criteria	and	share	this	information	with	the	anesthesiologist.	The	
management	of	anesthesia	in	patients	with	a	high	risk	for	bleed-
ing	should	begin	in	the	antenatal	period	and	precautions	should	
be	taken	against	possible	complications.	 
References 
  1. Parekh N, Husaini S, Russell I. Caesarean section for placenta praevia: a retrospective study of 
anaesthetic management. Br J Anaesth. 2000, 84, 725-730. 
  2. McShane P, Heyl P, Epstein M. Maternal and perinatal morbidity resulting from placenta previa. 
Obstet Gynecol. 1985, 65, 176-182. 
  3. Bauer S, Bonanno C. Abnormal placentation. Semin Perinatol. 2009, 33, 88-96. 
  4. Timmermans S, van Hof A, Duvekot J. Conservative management of abnormally invasive 
placentation. Obstet Gynecol Surv. 2007, 62, 529-539. 
  5. Kuczkowski K. Anesthesia for the repeat cesarean section in the parturient with abnormal 
placentation: What does an obstetrician need to know? Arch Gynecol Obstet. 2006, 273, 319-
321. 
  6. Breen J, Neubecker R, Gregori C, Franklin J Jr. Placenta accreta, increta, and percreta: A survey 
of 40 cases. Obstet Gynecol. 1977, 49, 43-47. 
  7. Weiniger C, Elram T, Ginosar Y, [et al.]. Anaesthetic management of placenta accreta: use of a 
pre-operative high and low suspicion classification. Anaesthesia. 2005, 60, 1079-1084. 
  8. Hong J, Jee Y, Yoon H, Kim S. Comparison of general and epidural anesthesia in elective 
cesarean section for placenta previa totalis: maternal hemodynamics, blood loss and neonatal 
outcome. Int J Obstet Anesth. 2003, 12, 12-16.  
  9. Hsu T. Abnormal invasive placentation - placenta previa increta and percreta. Taiwan J Obstet 
Gynecol. 2009, 48, 38-45. 
10. Iyasu S, Saftlas A, Rowley D, [et al.]. The epidemiology of placenta previa in the United States, 
1979 through 1987. Am J Obstet Gynecol. 1993, 168, 1424-1429. 
11. Rosenberg T, Pariente G, Sergienko R, [et al.]. Critical analysis of risk factors and outcome of 
placenta previa. Arch Gynecol Obstet. 2011, 284, 47-51.  
12. Clark S, Koonings P, Phelan J. Placenta previa/accreta and prior cesarean section. Obstet 
Gynecol. 1985, 66, 89-92.  
13. Miller D, Chollet J, Goodwin T. Clinical risk factors for placenta previa-placenta accreta. Am J 
Obstet Gynecol. 1997, 177, 210-214. 
14. Usta I, Hobeika E, Musa A, [et al.]. Placenta previa-accreta: risk factors and complications. Am 
J Obstet Gynecol. 2005, 193, 1045-1049. 
15. Bonner S, Haynes S, Ryall D. The anaesthetic management of caesarean section for placenta 
praevia: a questionnaire survey. Anaesthesia. 1995, 50, 992-994.  
16. Imarengiaye C, Osaigbovo E, Tudjegbe S. Anesthesia for cesarean section in pregnancies 
complicated by placenta previa. Saudi Med J. 2008, 29, 688-691.  
17. Oyelese Y, Smulian J. Placenta previa, placenta accreta, and vasa previa. Obstet Gynecol. 
2006, 107, 927-941.  
18. Camann W, Biehl D. Antepartum and postpartum hemorrhage. In: Shnider and Levinson’s 
Anesthesia for Obstetrics. 4th Ed. Eds. Shnider S, Levinson G. Philadelphia: Lippincott Williams 
& Wilkins, 2002, 361-371.  
19. Ferrazzani S, Guariglia L, Triunfo S, [et al.]. Conservative management of placenta previa-
accreta by prophylactic uterine arteries ligation and uterine tamponade. Fetal Diagn Ther. 2009, 
25, 400-403.  
20. Kainer F, Hasbargen U. Emergencies associated with pregnancy and delivery: peripartum 
hemorrhage. Dtsch Arztebl Int. 2008, 105, 629-638.  
21. Price F, Resnik E, Heller K, Christopherson W. Placenta previa percreta involving the urinary 
bladder: a report of two cases and review of the literature. Obstet Gynecol. 1991, 78, 508-
511.  
